Home
Conditions
Pediatric Solid Tumor

Clinical trial condition

Pediatric Solid Tumor

Explore clinical trials studying Pediatric Solid Tumor. Study availability and eligibility vary by location and protocol.

19 public trials 8 recruiting studies

Refine in advanced search Browse all conditions

Pediatric Solid Tumor trial results

Recruiting

B7-H3.CD28Z.CART in Solid Tumors

NCT07358260

Conditions: Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +8 more
Locations: Dana Farber Cancer Institite Boston, Massachusetts, United States

View Trial Details

Recruiting Featured Trial

Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors

NCT03739827

Conditions: Malignant Solid Tumors, Other Neoplasms Solid Tumors, Pediatric Solid Tumor, +2 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

Oregon Health and Science University Portland, Oregon, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Recruiting

Metarrestin (ML-246) in Subjects With Metastatic Solid Tumors

NCT04222413

Conditions: Advanced Breast Cancer, Advanced Solid Tumors, Colonic Diseases, +32 more
Locations: University of Kansas Fairway, Kansas, United States

National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Recruiting

Targeting Pediatric Brain Tumors and Relapsed/Refractory Solid Tumors With Sodium Glucose Cotransporter 2 Inhibitors (SGLT2i)

NCT05521984

Conditions: Pediatric Brain Tumor, Pediatric Solid Tumor
Locations: Washington University School of Medicine/St. Louis Children's Hospital St Louis, Missouri, United States

View Trial Details

Recruiting

Multiomic Approach to Radioresistance of Ependymomas in Children and Adolescents

NCT05151718

Conditions: Ependymoma of Brain, Familial ependymoma, Pediatric Solid Tumor
Locations: Institut Claudius Regaud Toulouse, France

View Trial Details

Recruiting

Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients

NCT05468359

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +15 more
Locations: Methodist Le Bonheur Healthcare Germantown, Tennessee, United States

St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR)

NCT04897321

Conditions: Adrenal Cortex Diseases, Adrenal Cortex Neoplasms, Adrenal Gland Diseases, +65 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Recruiting

UGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumors

NCT06760117

Conditions: Pediatric Solid Tumor
Locations: Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China

View Trial Details

Active, not recruiting

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

NCT04483778

Conditions: Carcinoma, Clear Cell Sarcoma, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +66 more
Locations: Seattle Children's Hospital Seattle, Washington, United States

View Trial Details

Active, not recruiting

The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study

NCT02520713

Conditions: Pediatric Solid Tumor
Locations: University of California San Francisco San Francisco, California, United States

Children's Hospital Colorado Aurora, Colorado, United States

Children's National Medical Center Washington D.C., District of Columbia, United States

University of Chicago Comer Children's Hospital Chicago, Illinois, United States

View Trial Details

Pediatric Solid Tumor

Pediatric Solid Tumor trial results

Related conditions